We recently compiled a list of the 10 Buzzing AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive ...

Piper Sandler dipped into the beverage sector on Tuesday by issuing new Overweight ratings on Coca-Cola ( NYSE: KO) and ...

Autodesk (NASDAQ:ADSK) was upgraded to Overweight from Neutral by Piper Sandler due in part to the recent slip in share price ...

Fintel reports that on January 8, 2025, Piper Sandler upgraded their outlook for Arthur J. Gallagher (NYSE:AJG) from Neutral ...

Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...

Piper Sandler upgraded Arthur J. Gallagher (AJG) to Overweight from Neutral with a price target of $315, up from $285. The firm believes ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of ...

Piper Sandler initiated coverage on soda stocks, rating PepsiCo (NASDAQ:PEP), Coca-Cola (NYSE:KO) “overweight,” and Neutral on Keurig Dr Pepper (NASDAQ:KDP).

Fintel reports that on January 2, 2025, Piper Sandler downgraded their outlook for Biogen (BRSE:BIIB) from Overweight to Neutral. There are 1,768 funds or institutions reporting positions in Biogen.

An increase in construction spending in November was too small to change a flattening trend, Piper Sandler economists write.